Skip to main content
  • Oral presentation
  • Open access
  • Published:

A Next Generation Sequencing approach to the mutational screening of patients affected with systemic autoinflammatory disorders: diagnosis improvement and interpretation of complex clinical phenotypes


Systemic autoinflammatory diseases (SAIDs) are a group of monogenic disorders characterized by inflammation which occurs in the absence of pathogenic auto-antibodies, auto-reactive T lymphocytes or other infective causes. More than 50% of SAID patients recruited to our Unit does not show any mutation at gene(s) tested by direct Sanger sequencing in the routine diagnosis. Clinical misdiagnosis, mutations in untested gene regions and genetic heterogeneity are possible explanations.


To improve both the molecular diagnosis and genotype interpretation of SAIDs, we aimed at the development of a Next Generation Sequencing based protocol, designed for the simultaneous screening of ten genes known to be involved in a remarkable proportion of SAIDs. Different bio-informatics approaches were taken into consideration in order to define the best pipeline for variants detection.

Patients and methods

A panel of gene amplicons specific for the diseases under study was designed through the Ion AmpliSeq™ designer software. Fifty SAID patients, already genotyped for the respective causative gene(s), were massively sequenced for the coding portions of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12, NOD2, PSTPIP1, IL1RN, LPIN2 and PSMB8. Three different bio-informatics pipelines, Ion Reporter™, CLC Bio Genomics Workbench, and GATK-based in-house workflow, were compared


The approach we propose here for NGS-based diagnosis of SAIDs, has resulted technically suitable, with a very high mean coverage (336X) and nearly full detection of variants. Besides expected mutation, we could also identify many unexpected variants that were all validated by Sanger sequencing and compared to assess true and false positive detection rates of the three workflows. Finally, the overall clinical picture of 34 patients were re-evaluated in the light of the new mutations found.


The present gene panel has resulted suitable for molecular diagnosis of SAIDs. Besides causative mutations, most patients have turned out to carry variants of unclear significance that will need further investigation. Moreover, genotype-phenotype correlation drawn in 34 patients has confirmed a remarkably difficult interpretation of NGS data in patients with an undefined or complex inflammatory phenotype. This supports the need of evidence-based and validated clinical criteria as crucial tools to be used concurrently with the genetic analysis for the final diagnosis and classification of SAIDs patients. In addition to setting a first approach to mutational detection in SAIDs, patients left without a clear diagnosis will be identified as candidate for the successive NGS analysis of the whole exome.

Author information

Authors and Affiliations


Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rusmini, M., Federici, S., Caroli, F. et al. A Next Generation Sequencing approach to the mutational screening of patients affected with systemic autoinflammatory disorders: diagnosis improvement and interpretation of complex clinical phenotypes. Pediatr Rheumatol 13 (Suppl 1), O24 (2015).

Download citation

  • Published:

  • DOI: